1619
HR 3590 EAS/PP
this section that in the aggregate exceeds $10,000
1
per year. For purposes of the preceding sentence,
2
a financial benefit includes honoraria, fees, stock,
3
or other financial benefit and the current value
4
of the member or close relative's already existing
5
stock holdings, in addition to any direct finan-
6
cial benefit deriving from the results or findings
7
of a study conducted under this section.
8
``(b) P
ATIENT
-C
ENTERED
O
UTCOMES
R
ESEARCH
I
N
-
9
STITUTE
.--
10
``(1) E
STABLISHMENT
.--There is authorized to
11
be established a nonprofit corporation, to be known as
12
the `Patient-Centered Outcomes Research Institute'
13
(referred to in this section as the `Institute') which is
14
neither an agency nor establishment of the United
15
States Government.
16
``(2) A
PPLICATION OF PROVISIONS
.--The Insti-
17
tute shall be subject to the provisions of this section,
18
and, to the extent consistent with this section, to the
19
District of Columbia Nonprofit Corporation Act.
20
``(3) F
UNDING OF COMPARATIVE CLINICAL EF
-
21
FECTIVENESS RESEARCH
.--For fiscal year 2010 and
22
each subsequent fiscal year, amounts in the Patient-
23
Centered Outcomes Research Trust Fund (referred to
24
in this section as the `PCORTF') under section 9511
25